Authors
Loading...
Randomized trial shows CD154 enhances chemokine production and leukocyte migration in human endothelial cells, suggesting therapeutic targets for inflammation.
Thienel et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: